Inventors:
Paul Anthony TALBOT - Indianapolis IN, US
International Classification:
A61K 38/05, A61P 3/00, A61P 3/06, A61P 3/04, A61P 9/12, A61K 31/401, A61P 3/10
US Classification:
514 48, 514423, 514 68, 514 162, 514 163, 514 74
Abstract:
The present invention provides methods for treating, preventing, and/or delaying the onset of metabolic disorders including multi-factorial syndromes such as insulin-insensitivity and metabolic syndrome by administering an effective amount of an ACE inhibitor.